These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10961808)

  • 21. Peripheral blood mononuclear cell (PBMC) responsiveness in patients with head and neck cancer in relation to tumour stage and prognosis.
    Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
    Acta Otolaryngol; 1999 Mar; 119(2):281-4. PubMed ID: 10320092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients.
    Turksma AW; Bontkes HJ; van den Heuvel H; de Gruijl TD; von Blomberg BM; Braakhuis BJ; Leemans CR; Bloemena E; Meijer CJ; Hooijberg E
    Oral Dis; 2013 Sep; 19(6):577-84. PubMed ID: 23176702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-lymphocyte subsets in patients with squamous cell carcinoma of the head and neck.
    Furusaka T; Yokode Y; Nakajima M; Iida H; Kida A; Kikuchi K; Tomita H
    Auris Nasus Larynx; 1986; 13 Suppl 1():S143-8. PubMed ID: 3490251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients.
    Bose A; Chakraborty T; Chakraborty K; Pal S; Baral R
    Cancer Immun; 2008 Jun; 8():10. PubMed ID: 18547033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional alteration of myeloid dendritic cells through head and neck cancer.
    Brocks CP; Pries R; Frenzel H; Ernst M; Schlenke P; Wollenberg B
    Anticancer Res; 2007; 27(2):817-24. PubMed ID: 17465207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell abundance in blood predicts acute organ toxicity in chemoradiotherapy for head and neck cancer.
    Beschel LM; Leu M; Reichardt SD; Rave-Fränk M; Schirmer MA; Stadelmann C; Canis M; Wolff HA; Reichardt HM
    Oncotarget; 2016 Oct; 7(40):65902-65915. PubMed ID: 27589568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma.
    Molling JW; Langius JA; Langendijk JA; Leemans CR; Bontkes HJ; van der Vliet HJ; von Blomberg BM; Scheper RJ; van den Eertwegh AJ
    J Clin Oncol; 2007 Mar; 25(7):862-8. PubMed ID: 17327607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development.
    Kesselring R; Thiel A; Pries R; Trenkle T; Wollenberg B
    Br J Cancer; 2010 Oct; 103(8):1245-54. PubMed ID: 20877351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease stage related in vitro responsiveness of peripheral blood T-lymphocytes in patients with head and neck carcinoma.
    Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
    Acta Otolaryngol; 1998 Nov; 118(6):887-91. PubMed ID: 9870639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune alterations and immunotherapy prospects in head and neck cancer.
    Varilla V; Atienza J; Dasanu CA
    Expert Opin Biol Ther; 2013 Sep; 13(9):1241-56. PubMed ID: 23789839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma.
    Van Hal NL; Van Dongen GA; Ten Brink CB; Heider KH; Rech-Weichselbraun I; Snow GB; Brakenhoff RH
    Clin Cancer Res; 1999 Nov; 5(11):3534-41. PubMed ID: 10589769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease.
    Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
    Adv Otorhinolaryngol; 2005; 62():161-72. PubMed ID: 15608426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immune signature of CD8(+)CCR7(+) T cells in the peripheral circulation associates with disease recurrence in patients with HNSCC.
    Czystowska M; Gooding W; Szczepanski MJ; Lopez-Abaitero A; Ferris RL; Johnson JT; Whiteside TL
    Clin Cancer Res; 2013 Feb; 19(4):889-99. PubMed ID: 23363813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
    Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
    Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency.
    Slatter MA; Brigham K; Dickinson AM; Harvey HL; Barge D; Jackson A; Bown N; Flood TJ; Cant AJ; Abinun M; Gennery AR
    J Allergy Clin Immunol; 2008 Feb; 121(2):361-7. PubMed ID: 18086494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokines in head and neck cancer.
    Pries R; Wollenberg B
    Cytokine Growth Factor Rev; 2006 Jun; 17(3):141-6. PubMed ID: 16540364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis.
    Rabassa ME; Croce MV; Pereyra A; Segal-Eiras A
    BMC Cancer; 2006 Oct; 6():253. PubMed ID: 17064405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymostimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma.
    Kerrebijn JD; Simons PJ; Balm AJ; Tas M; Knegt PP; de Vries N; Tan IB; Drexhage HA
    Head Neck; 1996; 18(4):335-42. PubMed ID: 8780944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.